FR2843301B1 - GALENIC FORM FOR THE COLIC DELIVERY OF ACTIVE INGREDIENTS - Google Patents

GALENIC FORM FOR THE COLIC DELIVERY OF ACTIVE INGREDIENTS

Info

Publication number
FR2843301B1
FR2843301B1 FR0210151A FR0210151A FR2843301B1 FR 2843301 B1 FR2843301 B1 FR 2843301B1 FR 0210151 A FR0210151 A FR 0210151A FR 0210151 A FR0210151 A FR 0210151A FR 2843301 B1 FR2843301 B1 FR 2843301B1
Authority
FR
France
Prior art keywords
colic
delivery
active ingredients
galenic form
galenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0210151A
Other languages
French (fr)
Other versions
FR2843301A1 (en
Inventor
Sandrine Bourgeois
Elias Fattal
Antoine Andremont
Patrick Couvreur
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Assistance Publique Hopitaux de Paris APHP
Da Volterra SAS
Universite Paris Saclay
Universite Paris Cite
Original Assignee
Centre National de la Recherche Scientifique CNRS
Da Volterra SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Da Volterra SAS filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0210151A priority Critical patent/FR2843301B1/en
Priority to FR0213514A priority patent/FR2843302B1/en
Priority to US10/524,318 priority patent/US7485294B2/en
Priority to AT03758212T priority patent/ATE432066T1/en
Priority to EP03758212A priority patent/EP1526841B1/en
Priority to EP20080163660 priority patent/EP1992336A3/en
Priority to DE60327772T priority patent/DE60327772D1/en
Priority to CA002495291A priority patent/CA2495291A1/en
Priority to JP2004528586A priority patent/JP2006500359A/en
Priority to AU2003274229A priority patent/AU2003274229B2/en
Priority to PCT/FR2003/002474 priority patent/WO2004016248A2/en
Priority to ES03758212T priority patent/ES2327630T3/en
Priority to MXPA05001607A priority patent/MXPA05001607A/en
Priority to BR0313469-5A priority patent/BR0313469A/en
Priority to KR1020057002387A priority patent/KR101080577B1/en
Priority to CN038213656A priority patent/CN1681480B/en
Publication of FR2843301A1 publication Critical patent/FR2843301A1/en
Application granted granted Critical
Publication of FR2843301B1 publication Critical patent/FR2843301B1/en
Priority to US12/345,647 priority patent/US7833765B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR0210151A 2002-08-09 2002-08-09 GALENIC FORM FOR THE COLIC DELIVERY OF ACTIVE INGREDIENTS Expired - Lifetime FR2843301B1 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
FR0210151A FR2843301B1 (en) 2002-08-09 2002-08-09 GALENIC FORM FOR THE COLIC DELIVERY OF ACTIVE INGREDIENTS
FR0213514A FR2843302B1 (en) 2002-08-09 2002-10-29 GALENIC FORM FOR COLLECTIVE DELIVERY OF ACTIVE PRINCIPLES
ES03758212T ES2327630T3 (en) 2002-08-09 2003-08-06 GALENIC FORM FOR THE COLICO SUPPLY OF ACTIVE PRINCIPLES.
EP03758212A EP1526841B1 (en) 2002-08-09 2003-08-06 Galenic formulation for colon targeted delivery of active principles
EP20080163660 EP1992336A3 (en) 2002-08-09 2003-08-06 Dosage form for the administration of active agents in the colon
DE60327772T DE60327772D1 (en) 2002-08-09 2003-08-06 DRUGS FOR DRUG DISPERSION OF ACTIVE SUBSTANCES
CA002495291A CA2495291A1 (en) 2002-08-09 2003-08-06 Galenic formulation for colon targeted delivery of active principles
JP2004528586A JP2006500359A (en) 2002-08-09 2003-08-06 Galen formulation form for targeted delivery of active ingredients to the colon
US10/524,318 US7485294B2 (en) 2002-08-09 2003-08-06 Galenic pectinate formulation for colon-targeted delivery of antibiotic-inactivating enzymes and method of use thereof
PCT/FR2003/002474 WO2004016248A2 (en) 2002-08-09 2003-08-06 Galenic formulation for colon targeted delivery of active principles
AT03758212T ATE432066T1 (en) 2002-08-09 2003-08-06 MEDICINAL PRODUCTS FOR THE LARGE INTESTINE ADMINISTRATION OF ACTIVE INGREDIENTS
MXPA05001607A MXPA05001607A (en) 2002-08-09 2003-08-06 Galenic formulation for colon targeted delivery of active principles.
BR0313469-5A BR0313469A (en) 2002-08-09 2003-08-06 Galemic form for colic release of active principles
KR1020057002387A KR101080577B1 (en) 2002-08-09 2003-08-06 Galenic form colon-targeted delivery of active ingredients
CN038213656A CN1681480B (en) 2002-08-09 2003-08-06 Galenic formulation for colon targeted delivery of active principles
AU2003274229A AU2003274229B2 (en) 2002-08-09 2003-08-06 Galenic formulation for colon targeted delivery of active ingredients
US12/345,647 US7833765B2 (en) 2002-08-09 2008-12-29 Galenic formulation for colon-targeted delivery of active ingredients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0210151A FR2843301B1 (en) 2002-08-09 2002-08-09 GALENIC FORM FOR THE COLIC DELIVERY OF ACTIVE INGREDIENTS

Publications (2)

Publication Number Publication Date
FR2843301A1 FR2843301A1 (en) 2004-02-13
FR2843301B1 true FR2843301B1 (en) 2004-10-22

Family

ID=30471041

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0210151A Expired - Lifetime FR2843301B1 (en) 2002-08-09 2002-08-09 GALENIC FORM FOR THE COLIC DELIVERY OF ACTIVE INGREDIENTS

Country Status (1)

Country Link
FR (1) FR2843301B1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0606943A2 (en) * 2005-02-09 2009-07-28 Da Volterra delivery of active agents to the colon
US8273376B2 (en) 2006-11-17 2012-09-25 Da Volterra Colonic delivery of metallo-dependent enzymes
FR2950252B1 (en) 2009-09-23 2012-01-20 Centre Nat Rech Scient GALENIC FORM CAPABLE OF ADSORBER IN A SPECIFIC MANNER THE UNDESIRABLE MOLECULES
WO2018237000A1 (en) * 2017-06-20 2018-12-27 Seattle Gummy Company Pectin gummy compostion and methods of making and using thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959457A (en) * 1970-06-05 1976-05-25 Temple University Microparticulate material and method of making such material
SE459005B (en) * 1985-07-12 1989-05-29 Aake Rikard Lindahl SET TO MANUFACTURE SPHERICAL POLYMER PARTICLES
FR2608456B1 (en) * 1986-12-18 1993-06-18 Mero Rousselot Satia MICROCAPSULES BASED ON GELATIN AND POLYSACCHARIDES AND PROCESS FOR OBTAINING THEM
US4963368A (en) * 1988-04-18 1990-10-16 Nabisco Brands, Inc. Oxidoreductase enzyme stabilized highly unsaturated fatty acids and derivatives of such acids
DK0454044T3 (en) * 1990-04-25 1996-04-22 Hoechst Ag Pharmacological preparation containing polyelectrolyte complexes in microparticle form and at least one active substance
JPH0413741A (en) * 1990-05-02 1992-01-17 Chisso Corp Polyelectrolyte complex of pectin-polylysine
SE9002339L (en) * 1990-07-04 1992-01-05 Kabi Pharmacia Ab THERAPEUTIC COMPOSITION AND PROCEDURE FOR ITS PREPARATION
KR930006431B1 (en) * 1990-10-11 1993-07-16 재단법인 한국화학연구소 Microcapsulation of drugs
FI920206A0 (en) * 1992-01-17 1992-01-17 Pekka Untamo Heino MEDICINSK ANVAENDNING, MEDICINSKT FOERFARANDE OCH PREPARAT.
ES2133633T3 (en) * 1992-01-17 1999-09-16 Alfatec Pharma Gmbh PROCEDURE FOR THE PRODUCTION OF POWDERS, GRANULATES OR PELETS CONTAINING AN ACTIVE SUBSTANCE, WITH A STRUCTURE BASED ON HYDROPHILIC MACROMOLECULES, AND THEIR USE.
US5718969A (en) * 1993-08-25 1998-02-17 Fmc Corporation Nonaggregating hydrocolloid microparticulates, intermediates therefor, and processes for their preparation
AU1751997A (en) * 1996-01-30 1997-08-22 Advanced Polymer Systems Inc. Targeted delivery of drugs to the lower gastrointestinal tract

Also Published As

Publication number Publication date
FR2843301A1 (en) 2004-02-13

Similar Documents

Publication Publication Date Title
FR2906140B1 (en) GALENIC FORM FOR TRANSMUCOSUS ADMINISTRATION OF ACTIVE INGREDIENTS
NO20043998L (en) Oral administration for heavily soluble basic active ingredients
AP2004002982A0 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain.
AU2003261167A1 (en) Liquid dosage compositions of stable nanoparticulate active agents
IL157741A0 (en) Pharmaceutical compositions containing an antihyperplastic active agent
ZA200405657B (en) Formulation & dosage form for the controlled delivery of therapeutic agents.
FR2830447B1 (en) MICROPARTICULAR ORAL GALENIC FORM FOR DELAYED AND CONTROLLED RELEASE OF PHARMACEUTICAL ACTIVE INGREDIENTS
HK1116088A1 (en) Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
HK1073997A1 (en) Administration of agents for the treatment of inflammation
IT1318649B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MUCOSITES AND STOMATITIS.
DK1526839T3 (en) Oral pharmaceutical forms of liquid drugs with improved bioavailability
FR2873585B1 (en) NEW GALENIC FORMULATIONS OF ACTIVE PRINCIPLES
IS8430A (en) Medicines containing (2R) -2-propyl octanoic acid as the active ingredient
MXPA05007609A (en) CaSR ANTAGONIST.
MXPA03010054A (en) Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents.
WO2004098577A3 (en) Dosage form containing (s)-pantoprazole as active ingredient
FR2843301B1 (en) GALENIC FORM FOR THE COLIC DELIVERY OF ACTIVE INGREDIENTS
MA27689A1 (en) ORAL GALENIC FORM FOR CONTROLLED DRUG DELIVERY
TW200519102A (en) Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
ITMI20022358A1 (en) EFFERVESCENT PHARMACEUTICAL COMPOSITIONS FOR THE REALIZATION OF NON-CONVENTIONAL SUSPENSIONS.
FR2920308B1 (en) PHARMACEUTICAL FORM FOR ORAL ADMINISTRATION OF ACTIVE INGREDIENTS.
FR2849379B1 (en) ENCAPSULATION OF LIPOSOLUBLES ACTIVE INGREDIENTS
FR2839645B1 (en) MULTILAMELLAR SYSTEM FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES (IN PARTICULAR DRUGS) BY ORAL INGESTION
ITRM20020357A0 (en) LIQUID COMPOSITION FOR THE ORAL ADMINISTRATION OF LORAZEPAM.
ITUD20030196A1 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL DOSAGES CONTAINING MANY ACTIVE PRINCIPLES.

Legal Events

Date Code Title Description
TQ Partial transmission of property

Owner name: ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, FR

Effective date: 20120803

Owner name: UNIVERSITE DE PARIS DIDEROT-PARIS7, FR

Effective date: 20120803

Owner name: DA VOLTERRA, FR

Effective date: 20120803

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20120803

Owner name: UNIVERSITE PARIS SUD 11, FR

Effective date: 20120803

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

GC Lien (pledge) constituted

Effective date: 20170913

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20

TQ Partial transmission of property

Owner name: UNIVERSITE PARIS-SACLAY, FR

Effective date: 20220425

Owner name: UNIVERSITE DE PARIS DIDEROT-PARIS7, FR

Effective date: 20220425

Owner name: ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, FR

Effective date: 20220425

Owner name: DA VOLTERRA, FR

Effective date: 20220425

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20220425

CD Change of name or company name

Owner name: UNIVERSITE PARIS CITE, FR

Effective date: 20221006

Owner name: UNIVERSITE PARIS-SACLAY, FR

Effective date: 20221006

Owner name: ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, FR

Effective date: 20221006

Owner name: DA VOLTERRA, FR

Effective date: 20221006

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (, FR

Effective date: 20221006